NCT02816476
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- CHU d'Angers Angers, France
- CHU de Caen Caen, France
- CHU de Limoges Limoges, France
- CHU de Lyon Sud Lyon, France
Clinical trial condition
Proteostasis Deficiencies
Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.
1,351 public trials
352 recruiting studies
Proteostasis Deficiencies trial results
NCT02207556
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
- Locations
-
- Froedtert & Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT00647296
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- UCLA, Dept. of Neurology - Neuromuscular/ALS Research Center Los Angeles, California, United States
- The Forbes Norris MDA/ALS Research Center San Francisco, California, United States
- University of Colorado Health Sciences Center Aurora, Colorado, United States
NCT02686268
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic lateral sclerosis 1, C9orf72 Amyotrophic Lateral Sclerosis (ALS), +11 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
- Johns Hopkins Baltimore, Maryland, United States
- University of Massachusetts Amherst, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT04952025
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
NCT04950231
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Peking Yniversity Third Hospital Beijing, China
NCT04948346
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Peking University Third Hospital Beijing, China
Completed
Dexpramipexole Japanese PK Study
NCT01424163
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Research Site London, United Kingdom
NCT02936635
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics Phoenix, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California, Irvine Orange, California, United States
- UC Davis Medical Center Sacramento, California, United States
Completed
Phase 3 Study of Dexpramipexole in ALS
NCT01281189
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Barrow Neurological Institute - St. Joseph's Hospital Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of California at San Francisco - Fresno Fresno, California, United States
- University of California, Irvine Orange, California, United States